Anixa Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIX and other ETFs, options, and stocks.

About ANIX

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. 

CEO
Amit D. Kumar
CEOAmit D. Kumar
Employees
5
Employees5
Headquarters
San Jose, California
HeadquartersSan Jose, California
Founded
1982
Founded1982
Employees
5
Employees5

ANIX Key Statistics

Market cap
111.92M
Market cap111.92M
Price-Earnings ratio
-10.36
Price-Earnings ratio-10.36
Dividend yield
Dividend yield
Average volume
837.84K
Average volume837.84K
High today
$3.67
High today$3.67
Low today
$3.40
Low today$3.40
Open price
$3.60
Open price$3.60
Volume
176.93K
Volume176.93K
52 Week high
$5.46
52 Week high$5.46
52 Week low
$2.07
52 Week low$2.07

Stock Snapshot

Anixa Biosciences(ANIX) stock is priced at $3.40, giving the company a market capitalization of 111.92M. It carries a P/E multiple of -10.36.

During the trading session on 2025-12-17, Anixa Biosciences(ANIX) shares reached a daily high of $3.67 and a low of $3.40. At a current price of $3.40, the stock is 0.0% higher than the low and still -7.4% under the high.

Trading volume for Anixa Biosciences(ANIX) stock has reached 176.93K, versus its average volume of 837.84K.

Over the past 52 weeks, Anixa Biosciences(ANIX) stock has traded between a high of $5.46 and a low of $2.07.

Over the past 52 weeks, Anixa Biosciences(ANIX) stock has traded between a high of $5.46 and a low of $2.07.

ANIX News

TipRanks 5d
Anixa Biosciences Reports Positive Phase 1 Trial Results

Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper...

Benzinga 5d
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why

Anixa Biosciences Inc. (NASDAQ:ANIX) shares surged 15.21% in after-hours trading on Thursday, reaching $5.53, after the company presented final Phase 1 clinical...

TipRanks 6d
Anixa Biosciences says all primary endpoints met in breast cancer vaccine trial

Anixa Biosciences (ANIX) announced the presentation of final data from the Phase 1 clinical trial of its investigational breast cancer vaccine at the 2025 San A...

People also own

Based on the portfolios of people who own ANIX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.